Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer.

× No keyword cloud information.

50 in total

1. Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

Authors: Manfred Schmitt; Karin Mengele; Apostolos Gkazepis; Rudolf Napieralski; Viktor Magdolen; Ute Reuning; Nadia Harbeck
Journal: Breast Care (Basel) Date: 2008-10-15 Impact factor: 2.860

2. Prospective Biomarker Trials Chemo N0 and NNBC-3 Europe Validate the Clinical Utility of Invasion Markers uPA and PAI-1 in Node-Negative Breast Cancer.

Authors: Nadia Harbeck; Manfred Schmitt; Martina Vetter; Janna Krol; Daniela Paepke; Mathias Uhlig; Stefan Paepke; Fritz Jänicke; Anneke Geurts-Moespot; Gunter von Minckwitz; Fred Sweep; Christoph Thomssen
Journal: Breast Care (Basel) Date: 2008-10-16 Impact factor: 2.860

3. Biological indices in the assessment of breast cancer.

Authors: A S Leong; A K Lee
Journal: Clin Mol Pathol Date: 1995-10

Review 4. Utilizing prognostic and predictive factors in breast cancer.

Authors: Deepa S Subramaniam; Claudine Isaacs
Journal: Curr Treat Options Oncol Date: 2005-03

Review 5. The role of proteolytic enzymes in cancer invasion and metastasis.

Authors: M J Duffy
Journal: Clin Exp Metastasis Date: 1992-05 Impact factor: 5.150

6. Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.

Authors: S Shetty; S Idell
Journal: Mol Cell Biochem Date: 1999-09 Impact factor: 3.396

7. Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer.

Authors: H Ito; Y Yonemura; H Fujita; K Tsuchihara; T Kawamura; N Nojima; T Fujimura; H Nose; Y Endo; T Sasaki
Journal: Virchows Arch Date: 1996-02 Impact factor: 4.064

Review 8. Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients.

Authors: W C Wood
Journal: World J Surg Date: 1994 Jan-Feb Impact factor: 3.352

9. [The prognostic importance of urinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in the primary resection of oral squamous cell carcinoma].

Authors: B Hundsdorfer; H-F Zeilhofer; K P Bock; P Dettmar; M Schmitt; H-H Horch
Journal: Mund Kiefer Gesichtschir Date: 2004-02-06

10. [Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma].

Authors: B Hundsdorfer; H-F Zeilhofer; K P Bock; P Dettmar; M Schmitt; H-H Horch
Journal: Mund Kiefer Gesichtschir Date: 2004-02-06